BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2020 11:53:47 AM | Browse: 676 | Download: 699
 |
Received |
|
2020-03-02 00:25 |
|
Peer-Review Started |
|
2020-03-02 01:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-26 16:42 |
|
Revised |
|
2020-05-20 19:34 |
|
Second Decision |
|
2020-06-09 09:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-10 17:52 |
|
Articles in Press |
|
2020-06-10 17:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-28 13:45 |
|
Publish the Manuscript Online |
|
2020-07-07 11:53 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Thrombopoietin-receptor agonists in perioperative treatment of patients with chronic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kamran Qureshi and Alan Bonder |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alan Bonder, MD, Attending Doctor, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, 110 Francis St. Suite 8E, Boston, MA 02215, United States. abonder@bidmc.harvard.edu |
| Key Words |
Chronic liver disease; Thrombocytopenia; Thrombopoietin; Receptor agonist; Avatrombopag; Lusutrombopag |
| Core Tip |
Thrombocytopenia in patients with chronic liver disease complicates perioperative planning. Platelet transfusions are typically used as periprocedural treatment in these patients, but their use is complicated due to risk factors such as the development of infections and refractoriness. This has led to the development of thrombopoietin-receptor agonists, such as avatrombopag and lusutrombopag, that can increase platelet counts in patients with compromised thrombopoietin production and chronic liver disease. These thrombopoietin-receptor agonists can provide physicians with a safe and effective alternative to platelet transfusions and their use in clinical practice is the focus of this review. |
| Publish Date |
2020-07-07 11:53 |
| Citation |
Qureshi K, Bonder A. Thrombopoietin-receptor agonists in perioperative treatment of patients with chronic liver disease. World J Meta-Anal 2020; 8(3): 220-232 |
| URL |
https://www.wjgnet.com/2308-3840/full/v8/i3/220.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v8.i3.220 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
